TransMedics Group, Inc. (TMDX): A Bull Case Theory
We came across a bullish thesis on TransMedics Group, Inc. on Global Equity Briefing’s Substack by Ray Myers. In this article, we will summarize the bulls’ thesis on TMDX.
Transmedics Group Inc. (TMDX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Driehaus Capital Richard Driehaus | 854,039 | $114,449,766 | +10% | 0.92% |
| 2. | Hood River Capital Management David Swank | 679,847 | $91,106,296 | -15% | 1.27% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 546,787 | $73,274,926 | +259% | 0.08% |
| 4. | 409,900 | $54,930,699 | +41% | 0.01% | |
| 5. | 30,824,000 | $49,472,891 | 1.65% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $116.85 | 1,858 | $217,107.30 | 486,234 | 2025-08-07 | Filing | |
| $116.08 | 6,617 | $768,101.36 | 484,376 | 2025-08-07 | Filing | |
| $118.68 | 8,400 | $996,912.00 | 477,759 | 2025-08-06 | Filing | |
| $62.00 | 2,500 | $155,000.00 | 13,693 | 2023-08-29 | Filing | |
| $22.71 | 74,062 | $1,681,948.02 | 302,893 | 2021-11-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $125.51 | 4,143 | $519,987.93 | 2,866 | 2025-08-04 | Filing | |
| $139.80 | 686 | $95,902.80 | 13,955 | 2025-06-09 | Filing | |
| $126.45 | 5,000 | $632,250.00 | 2,866 | 2025-05-27 | Filing | |
| $123.88 | 732 | $90,680.16 | 12,134 | 2025-05-23 | Filing | |
| $115.63 | 6,000 | $693,780.00 | 732 | 2025-05-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,223,646 | $700,020,801 | 0.01% | |
| 2. | 5,023,740 | $673,231,415 | 0.04% | |
| 3. | 3,595,957 | $481,894,198 | 0.01% | |
| 4. | 181,374,000 | $291,079,209 | 1.79% | |
| 5. | 1,289,010 | $172,740,230 | 0.01% |
News See All
TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to TransMedics Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
Headwaters Capital Management Sold Transmedics (TMDX) After a Strong Q1 Report
Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Oppenheimer Raises TransMedics (TMDX) PT to $150 Following Key OrganOx Metra Label Update
TransMedics Group Inc. (NASDAQ:TMDX) is one of the best mid cap growth stocks to invest in now.
11 Best Mid Cap Growth Stocks To Invest In Now
On June 18, Scott Wren, Wells Fargo senior global market strategist, joined CNBC's 'Closing Bell Overtime' to talk about how the market sell-off is an opportunity to step in.
TransMedics (TMDX) Continues to Scale Innovation in Organ Transplant Care
TransMedics Group Inc. (NASDAQ:TMDX) is one of the 10 best growth stocks to buy according to billionaires.
10 Best Growth Stocks to Buy According to Billionaires
Growth stocks are companies that are expected to report above-average earnings and revenue growth.
TransMedics Group, Inc. (TMDX): A Bull Case Theory
We came across a bullish thesis on TransMedics Group, Inc. (TMDX) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc.
Piper Sandler Boosts TransMedics (TMDX) PT to $145, Keeps Overweight Rating
On Wednesday, Piper Sandler analyst Matt O’Brien raised the price target on TransMedics Group Inc. (NASDAQ:TMDX) to $145 from $125, while maintaining an Overweight rating on the shares.
11 Unstoppable Growth Stocks to Invest in Now
BlackRock highlighted that the trade conflict between the US and China continues to cause major economic disruptions.